Theophylline inhibits the late asthmatic response to nighttime antigen challenge in patients with mild atopic asthma.

[1]  E. Crimi,et al.  Bronchial and Bronchoalveolar Inflammation in Single Early and Dual Responders after Allergen Inhalation Challenge , 1997, Lung.

[2]  R. Martin,et al.  Theophylline's effect on neutrophil function and the late asthmatic response. , 1996, The Journal of allergy and clinical immunology.

[3]  S. Wenzel,et al.  Theophylline: potential antiinflammatory effects in nocturnal asthma. , 1996, The Journal of allergy and clinical immunology.

[4]  L. Hendeles,et al.  Theophylline in asthma. , 1996, The New England journal of medicine.

[5]  K. Chung,et al.  Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy. , 1995, American journal of respiratory and critical care medicine.

[6]  L. Hendeles,et al.  Theophylline attenuation of airway responses to allergen: comparison with cromolyn metered-dose inhaler. , 1995, The Journal of allergy and clinical immunology.

[7]  B. Make,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[8]  C. Page,et al.  Anti-inflammatory effects of low-dose oral theophylline in atopic asthma , 1994, The Lancet.

[9]  R. Pauwels,et al.  Theophylline in the management of asthma: time for reappraisal? , 1994, The European respiratory journal.

[10]  DuBuske Lm.  Asthma: diagnosis and management of nocturnal symptoms , 1994 .

[11]  L. Fabbri,et al.  Theophylline inhibits early and late asthmatic reactions induced by allergens in asthmatic subjects. , 1991, Annals of allergy.

[12]  R. Ballard,et al.  Airways inflammation in nocturnal asthma. , 1991, The American review of respiratory disease.

[13]  R. Martin,et al.  Circadian basis of the late asthmatic response. , 1990, The American review of respiratory disease.

[14]  S. Holgate,et al.  The effect of an increase in inhaled allergen dose after rimiterol hydrobromide on the occurrence and magnitude of the late asthmatic response and the associated change in nonspecific bronchial responsiveness. , 1989, The American review of respiratory disease.

[15]  M. Turner-Warwick,et al.  Epidemiology of nocturnal asthma. , 1988, The American journal of medicine.

[16]  W. Busse.  Pathogenesis and pathophysiology of nocturnal asthma. , 1988, The American journal of medicine.

[17]  P. O'Byrne,et al.  Late asthmatic responses. , 1987, The American review of respiratory disease.

[18]  J. Stewart,et al.  Once-daily sustained-release theophylline reduces diurnal variation in spirometry and symptomatology in adult asthmatics. , 1987, The American review of respiratory disease.

[19]  J. Stewart,et al.  Comparison of morning versus evening dosing with a new once-daily oral theophylline formulation. , 1985, The American journal of medicine.

[20]  E. R. Mcfadden,et al.  Pharmacokinetics and clinical response to single- and multiple-dose sustained-release theophylline compounds in perennial bronchial asthma. , 1985, The American journal of medicine.

[21]  R. Pauwels,et al.  The effect of theophylline and enprofylline on allergen-induced bronchoconstriction. , 1985, The Journal of allergy and clinical immunology.

[22]  H. Sluiter,et al.  Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. , 1985, The American review of respiratory disease.

[23]  S. Spector,et al.  Standardization of bronchial inhalation challenge procedures. , 1975, The Journal of allergy and clinical immunology.